# OnCo record nct03793478 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct03793478/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct03793478", "NCT03793478" ;
  schema:name "Safety and Efficacy of Quizartinib in Children and Young Adults With Acute Myeloid Leukemia (AML), a Cancer of the Blood"@en ;
  schema:description "A phase 1/2 trial of Quizartinib, Fludarabine, Cytarabine and Etoposide in acute myeloid leukaemia, run by Daiichi Sankyo, active and no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/nct03793478/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT03793478> ;
  onco:status "active" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "1/2" ;
  schema:startDate "2018-08-15" ;
  onco:cancers <https://onco.cc/cancers/aml/>, <https://onco.cc/cancers/aml-flt3/>, <https://onco.cc/cancers/aml-paediatric/> ;
  onco:technologies <https://onco.cc/technologies/kinase-inhibitors/> ;
  onco:drugs <https://onco.cc/drugs/quizartinib/>, <https://onco.cc/drugs/fludarabine/>, <https://onco.cc/drugs/cytarabine/>, <https://onco.cc/drugs/etoposide/> ;
  onco:companies <https://onco.cc/companies/daiichi-sankyo/> .